Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News > 2024 > Alvotech moves to bring its Humira biosimilar to US market

Alvotech moves to bring its Humira biosimilar to US market

Alvotech moves to bring its Humira biosimilar to US market

Read also

FDA Approves At-Home Lasix for Heart Failure

FDA Approves At-Home Lasix for Heart Failure

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by...

Lupin's New Jersey Facility Passes FDA

Lupin's New Jersey Facility Passes FDA

Lupin's New Jersey Facility Passes FDA Inspection; Plans $250M Investment in Florida

Adults 65 years and older not immune to the opioid epidemic, new study finds

Adults 65 years and older not immune to the opioid epidemic, new study finds

SAN ANTONIO — Overdose deaths in adults age 65 and older from fentanyl mixed with stimulants, such as cocaine and methamphetamines, have surged 9,000% in the past eight years

Ireland’s largest cancer research initiative launches second phase

Ireland’s largest cancer research initiative launches second phase

The second phase of Precision Oncology Ireland (POI), the country’s largest cancer research programme has been launched by James Lawless, minister for Further and Higher Education, Research,...